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Ten patients with nonobstructive hypertrophic cardio-
myopathy and only mild localized left ventricular hy-
pertrophy who had severe symptoms of cardiac failure
are described. During a mean follow-upperiod of7 years,
6 of these 10 patients showed a substantial increase in
left ventricular internal dimension (6 to 15 mm, mean
10) as assessed with M-mode echocardiography, al-
though absolute left ventricular cavitysizeremained within
normal limits in 5 of the 6. Four patients demonstrated
substantial septal thinning (5 to 14 mm, mean 8). Left
ventricular diastolic function, assessed by radionuclide
angiography in nine patients, was impaired in eight who
showed decreased peak filling rate « 2.5 end-diastolic
volumes/s) and prolonged time to peak rate of filling
(~180 ms). Furthermore, left ventricular systolic func-
tion, usually supernormal in patients with hypertrophic
In patients with hypertrophic cardiomyopathy, marked left
ventricular hypertrophy is considered to be a major deter-
minant of diastolic dysfunction (1-3). However, we have
recently shown that patients with hypertrophic cardio-
myopathy who have only mild localized left ventricular
hypertrophy may also demonstrate diastolic impairment (4),
This observation would suggest that the primary cardio-
myopathic process in hypertrophic cardiomyopathy is not
necessarily limited to areas of wall thickening, and that
factors other than hypertrophy may playa major role in the
genesis of left ventricular dysfunction in patients with this
disease.
In the present investigation, we describe a subset of pa-
tients with nonobstructive hypertrophic cardiomyopathy who
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cardiomyopathy, was depressed (ejectionfraction ~45%)
in six patients.
Hence, a subset of patients was identified with non-
obstructive hypertophic cardiomyopathy and only mild
localized left ventricular hypertrophy who experienced
severe cardiac symptoms. The majority of these patients
showed both systolic and diastolic left ventricular dys-
function in the presence of a progressive increase in left
ventricular internal dimension (but without absolute left
ventricular dilation) or ventricular septal thinning or
both. Such patients may represent an important com-
ponent of the natural history of hypertrophic cardio-
myopathy which has not been previously fully appre-
ciated.
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were severely symptomatic but had only mild localized left
ventricular hypertrophy. The purpose of this study was to
define the morphologic, functional and clinical profile of
such patients and to derive insights regarding the determi-
nants of severe symptoms in the absence of severe left
ventricular hypertrophy.
Methods
Selection and Characterization of Patients
Severely symptomatic patients. Ten patients with hy-
pertrophic cardiomyopathy constitute the present study group.
Each patient was selected after a review of the 1984 two-
dimensional echocardiographic registry of the Echocardi-
ography Laboratory of the National Heart, Lung, and Blood
Institute, by virtue of meeting the following criteria: I) only
mild, localized left ventricular hypertrophy (assessed with
two-dimensional echocardiography as described later); 2)
absence of significant left ventricular outflow tract obstruc-
tion (gradient <30 mm Hg) under basal conditions; 3) mod-
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erate to severe functional limitation (New York Heart As-
sociation functional class III or IV); 4) no history of chronic
atrial fibrillation that could, in itself, explain the severity
of symptoms; and 5) technically satisfactory echocardio-
graphic studies recorded in 1984 and also at least 2 years
previously.
At some point during their clinical course, all study pa-
tients fulfilled the diagnostic criterion for hypertrophic car-
diomyopathy based on the M-mode or two-dimensional
echocardiographic demonstration and of a nondilated, hy-
pertrophied left ventricle, in the absence of another cardiac
or systemic disease that could produce left ventricular hy-
pertrophy (5). Absence of significant left ventricular outflow
tract obstruction under basal conditions was documented at
cardiac catheterization in 9 of the 10 patients, and estimated
from the M-mode echocardiogram (based on the absence of
systolic anterior motion of the mitral valve) in I patient
(6,7).
The 10 patients ranged in age from 18 to 71 years (mean
46) at the time of their most recent evaluation; 6 were women
and 4 were men. Duration of follow-up between the initial
and most recent evaluation was 2 to II years (mean 7). The
initial evaluation was defined as the first clinical assessment
at our institution during which a technically satisfactory M-
mode echocardiogram was obtained. Significant narrowing
of the extramural coronary arteries was excluded by coro-
nary arteriography in five patients; in four other patients the
presence of coronary artery disease was considered unlikely
because of sex (female) and youthful age «40 years). Coro-
nary artery disease could not be excluded definitely in one
man who was 71 years old at the most recent evaluation;
he had never, however, experienced angina pectoris.
Asymptomatic or mildly symptomatic patients. In ad-
dition, 17 other patients with nonobstructive hypertrophic
cardiomyopathy who also had their most recent echocar-
diographic study during 1984 were included in this inves-
tigation for the purpose of comparison. These 17 patients
had morphologic features similar to those of the 10 severely
symptomatic patients (that is, mild, localized left ventricular
hypertrophy) but, in contrast, had no or only mild symptoms
(functional class I or II). Each of these 17 patients had a
clinical and echocardiographic follow-up of at least 2 years
(up to II years, mean 6). These patients ranged in age from
14 to 64 years (mean 40) at the time of their most recent
evaluation; 14 were men and 3 were women. In each patient,
absence of significant left ventricular outflow tract obstruc-
tion under basal conditions was estimated from the M-mode
echocardiogram (based on the absence of systolic anterior
motion of the mitral valve) (6,7).
Echocardiography
Two-dimensional echocardiography. A Varian (V-3000
or V-3400) real-time, phased array, ultrasound sector scan-
ner (80°) with a 2.25 MHz transducer, or an Advanced
Technology Laboratory (ATL) Mark 500 mechanical sector
scanner (84°) with a 3 MHz transducer was used to perform
the two-dimensional echocardiographic studies. Images were
recorded on I inch (2.54 ern) reel-to-reel videotape. The
two-dimensional echocardiographic images were obtained
in the parasternal long-axis and short-axis views and apical
two and four chamber views using standard transducer po-
sitions (8).
Two-dimensional echocardiography was utilized in this
study to identify patients with hypertrophic cardiomyopathy
who had mild, localized left ventricular hypertrophy. The
magnitude of left ventricular hypertrophy was assessed pri-
marily from the parasternal short-axis plane; however, the
parasternal long-axis and apical views were also used to
integrate the information obtained from the short-axis views
(4,9). In the parasternal short-axis plane, the left ventricle
was divided into four regions that identified the anterior and
posterior ventricular septum and the lateral and posterior
left ventricular free walls (Fig. I) (4). Wall thickness was
assessed directly from the television monitor with the aid
of calipers, using a calibration scale produced by the in-
strument. Location of endocardial and epicardial borders
was identified by viewing the pertinent portions of videotape
in slow motion and real-time modes. In certain instances,
wall thickness was also measured in the stop-action
mode (4,9).
Hypertrophy of the anterior ventricular septum or the
posterior free wall was considered to be present if the di-
astolic thickness of the wall was at least 15 mm (4,9). The
Figure 1. Segments of left ventricular wall visualized by two-
dimensional echocardiography in the short-axis view. The points
of insertion of the right ventricle into the left ventricle are the
anatomic landmarks dividing the ventricular septum (VS) from the
left ventricular free wall. A = anterior; L = left; P = posterior;
R = right. (Reprinted by permission of the American Heart As-
sociation, Inc. from Spirito et al. [4].)
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Figure 2. Stop frames of two-dimensional echocar-
diograms (during diastole) from a patient with hyper-
trophic cardiomyopathy and mild left ventricular hy-
pertrophy. Parasternal short-axis view at chordal (MV)
level (A) showing localized hypertrophy of the anterior
ventricular septum (VS); parasternal long-axis (B) and
apical four chamber (C) views showing hypertrophy
confined to the most basal portion of the ventricular
septum. Each two-dimensional stop frame is accom-
panied by a schematic illustration. Ao = aorta; FW
= free wall; LA = left atrium; LV = left ventricle;
MV = mitral valve; PW = posterior wall; RV = right
ventricle. Calibration dots are I em apart.
posterior portion of the septum and anterolateral free wall
are visualized in the lateral regions of the sector (in the
short-axis plane), where resolution is less optimal (10).
Therefore, to ensure that the frequency with which hyper-
trophy in these segments was identified would not be over-
estimated, hypertrophy of the posterior septum and the lat-
eral free wall was defined as a wall thickness of at least 17
mm (4,9).
On the basis ofthese two-dimensional echocardiographic
criteria, the number of hypertrophied left ventricular seg-
ments was identified and the overall extent of left ventricular
hypertrophy was assessed. Hypertrophy was considered mild
if wall thickening was confined to only one of the four
segments in which the left ventricle had been divided
Fig. 2 (4).
M-mode echocardiography. M-mode echocardiograms
were obtained with a 2.25 MHz, unfocused Aerotech Trans-
ducer and a Hoffrel 101 ultrasound receiver interfaced with
a Honeywell 1856 strip chart recorder, or with an Irex Sys-
tem II ultrasound unit with either a 2.25 or 3.5 MHz trans-
ducer. The thickness of the ventricular septum and the left
ventricular posterior free wall, and left ventricular end-di-
astolic diameter were measured either at the mitral valve
level or just distal to the mitral valve leaflets, depending on
where septal thickness was maximal. Measurements of these
echocardiographic indexes were made at the peak of the R
wave of the electrocardiogram using the "leading edge"
method (II).
Echocardiographic measurements were obtained at both
the initial and the most recent evaluation. Each pair of
echocardiograms was coded and measurements were ob-
tained without knowledge of the identity of the patients. To
minimize errors inherent in the resolution capabilities of
echocardiography, changes in left ventricular wall thickness
and cavity dimension were considered to have occurred in
individual patients only if the difference between serial mea-
surements was 5 mm or more.
Radionuclide Angiography
Radionuclide angiography was performed at rest using
red blood cells labeled in vivo with 15 to 20 mCi of tech-
netium-99m, as previously described (12). Left ventricular
ejection fraction was calculated by computer analysis of
relative left ventricular end-diastolic and end-systolic counts.
Left ventricular diastolic filling was assessed utilizing
radionuclide angiographic indexes of peak filling rate and
time to peak filling rate (12). Peak filling rate was calculated
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Table 1. Serial M-Mode Echocardiographic Data in 27 Patients With Hypertrophic Cardiomyopathy and Mild Left Ventricular
Hypertrophy Including 10 Patients With Severe Symptoms and 17 Patients With No or Mild Symptoms
No. of
VS Thickness (mm) PW Thickness (mm) LVID (mm)
Patients II II II
No or mild symptoms 17 16 ± 4 16 ± 4 9 ± 2 9 ± 2 43 ± 4 44 ± 3
Severe symptoms 10 22 ± 7* 18 ± 4t 9 ± 2 9 ± 2 41 ± 6 47 ± 5:j:
*p < 0.02. when compared with the value obtained in patients with no or mild symptoms. tp < 0.05. when compared with the value obtained
from the initial echocardiogram; however. p > 0.05, when compared with the value in patients with no or mild symptoms. :j:p < 0.05, when compared
with the value obtained from the initial echocardiogram. I = initial echocardiographic examination; II = most recent echocardiographic examination
(an average of 7 years after the initial study); LVID = left ventricular internal end-diastolic dimension; PW = posterior free wall; VS = ventricular
septum.
by fitting a third-order polynomial function to the rapid
filling portion of the time-activity curve, using a least-squares
technique, and it was computed in counts per second, nor-
malized for the number of counts at end-diastole, and ex-
pressed as end-diastolic volume per second. Time to peak
filling rate was measured from end-systole (minimal volume
on the time-activity curve) to the time of peak rate of left
ventricular filling. Normal limits for these radionuclide an-
giographic indexes of diastolic filling have been previously
defined in our laboratory (12).
Statistical methods. Data were expressed as mean ±
SD. Differences between means were determined using the
Student's paired or unpaired t test, where appropriate.
Results
Changes in echocardiographic dimensions during fol-
low-up. In the 10 severely symptomatic patients, mean left
ventricular end-diastolic cavity dimension increased and mean
ventricular septal thickness decreased significantly between
Table 2. Clinical Data in 10 Patients With Nonobstructive Hypertrophic Cardiomyopathy, Mild
Left Ventricular Hypertrophy and Severe Cardiac Symptoms
M-Mode Echo- Radionuclide Angiogram
Age
cardiogram
EF PFR Time to PFR
(yr) VS LVIDd (%EDV) (EDV/s) (ms)
Case Examination & Sex FC (mm) (mm) (NL >45) (NL 2:2.5) (NL :sI80)
I 16F 2 9* 44 45 0.8 105
II 18 3 II 44
2t I 27F 2 24 37 50 2.5 157
II 31 4 22 45 43 3.7 161
3 I 37F 3 25 38 60 1.5 232
II 39 3 22 46
4 I 39F 3 21 47 45 2.4 139
II 42 4 18 50
5 I 34M 2 28 47 43 1.7 200
II 45 4 14 58 25 -:j:
6 I 36M 2 30 50 56 2.3 191
II 47 3 22 50
7 I 42F I 16 30 42 1.5 175
II 53 3 14 45
8 I 49M 3 15 37 84 1.3 247II 55 3 19 43
9 I 45F 3 28 40 40 1.9 159
II 55 4 23 41 27 1.5 146
10 I 63M 3 25 35 67 -:j:II 71 3 19 48
*Hypertrophy involved areas of the left ventricular wall not visualized by M-mode echocardiography (that
is, the lateral free wall); the thickness of this segment of the ventricular wall did not change during the period
of observation. tDied of progressive congestive heart failure during the follow-up period. :j:Diastolic function
could not be assessed because of sinus tachycardia. EF = ejection fraction; EDV = end-diastolic volume;
FC = functional class; LVIDd = left ventricular internal end-diastolic diameter; NL = normal; I and II = at
initial and most recent examination, respectively; PFR = peak filling rate; VS = ventricular septum.
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Figure 3. Left ventricular (LY) end-diastolic internal dimension
assessed by M-mode echocard iography in 10 patients with hyper-
trophic cardiomyopathy, mild hypertroph y and severe symptoms,
and in 17 patients with hypertroph ic cardiomyopathy, mild hy-
pertrophy, but no or only mild symptoms. Echocardiographic
(ECHO) measurements were obtained at the time of the initial (1)
and most recent (11) evaluations. Patients are separated into two
groups on the basis of the severity of cardiac symptoms. Dotted
line denotes upper limit of normal. N.S. = not significant.
81
Echocardiographic measurements in the 10 patients with
severe functional limitation were compared with measure-
ments in the 17 patients with no or only mild symptom s
(Table I . Fig. 3 and 6) . At the initial evaluation, ventricular
septal thickness was significantly greater in patients with
severe symptoms compared with those with no or only mild
symptoms (p < 0.02) . However , at the time of the most
recent eva luation, ventri cular septal thickness did not differ
significantly between the two groups, apparently because
of wall thinning in the patients with severe symptoms. Pos-
terior wall thickne ss and left ventricular end-diastolic cavity
dimension did not differ significantly between the two groups,
at either the initial or the most recent evaluation .
Left ventricular function on radionuclide angiogra-
phy. Radionuclide angiography was performed in each of
the 10 patients with seve re functional limitation . At the time
of the study, eight of these patient s were taking no car-
dioactive medication , whereas one patient was treated with
hydralazine, and one other with a combination of digoxin
and quinidine . In 6 of the 10 patient s, left ventricular systolic
function was depressed (rest ejection fraction :::::45%), and
Figure 4. Case 5 (Table 2). Serial M-mode echocardiograms
showing progressive thinning of the ventricular septum (YS) and
increase in left ventricular internal dimension (LYIDd) . A, At age
37, ventricular septal thickness is 20 mm and left ventricular in-
ternal dimension is 49 mm (this echocardiogram is not the initial
study obtained in this patient). B, Eight years later. thickness of
the ventricular septum is 14 mm and left ventricular internal di-
mension is 58 mm.
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the initial and most recent echocardiographic evaluation (Ta-
ble I). Analysis of individual patients showed that in 6 of
the 10 patients left ventricular end-di astolic dimension in-
creased by 6 to 15 mm (mean 10), constituting a chan ge of
16 to 50% (mean 28) (Table 2. Fig. 3). In five of these six
patient s. the absolute value for left ventricular end-diastolic
dimension remained within norm al limits at the most recent
evaluat ion (that is, 43 to 48 mm); the remaining patient had
absolute left ventricular dilation with cavi ty diastol ic di-
mension clearly increased (58 mm) over normal values (Fig .
4 (13). In four of the 10 patients , ventricular septal thickness
decreased by 5 to 14 mm (mean 8 mm) at the most recent
examination, constituting a change in thickness of 18 to
50% (mean 30) (Table 2, Fig 4 to 6).
In the 17 patients with mild left ventricular hypertrophy
who were asymptomatic or only mildly symptomatic , mean
left ventricular end-diastolic cav ity dimension and ventric-
ular septal thickness did not change significantly between
the initial and the most recent evaluations (Table I , Fig . 3
and 6) . F urthermore, when seria l echocardiographic mea-
surements were analyzed with regard to individual patient s,
no one in this group showed an increase in left ventricular
end-diastolic dimension or a decrease in ventricular septal
thickness of 5 mm or more . One patient did , however ,
demonstrate an increase in septal thickness of 7 mm during
the period of follow-up (between ages 14 and 24) ( 14) .
I OJ - - - - --- -- -- -- - - --~--
~ e_..9 9
~ 40 ' 9 ........~~=-e
c
u
::;
a
lii ~
-e
a L--N.S.----l L-p < O.Ol-J
6~ . N.S.-----'
~ 20 N.S.-----'
542 SPIRITO ET AL.
HYPERTROPHIC CARDIOMYOPATHY AND MILD HYPERTROPHY
lACC Vol. 8. No.3
September 1986:537-44
ECHOI ECHO II
SEVERE SYMPTOMS
ECHOI ECHOII
NO OR MILD SYMPTOMS
40 N.S.
p < 0.02
,-N.S.--, ,-p < 0.05--,
E 30
E
CIl 0-
CIl --0
w
z B-~ 20~ BJ:
I- B- B
..J
~
I-
a- 10w
CIl
Figure 6. Ventricular septal thickness assessed by M-mode echo-
cardiography in 10 patients with hypertrophic cardiomyopathy,
mild hypertrophy and severe symptoms, and in 17 patients with
hypertrophic cardiomyopathy, mild hypertrophy but no or only
mild symptoms. Echocardiographic (ECHO) measurements were
obtained at the time of the initial (I) and the most recent (II)
evaluations. Patients were separated into two groups on the basis
of the severity of cardiac symptoms. N.S. = not significant.
symptomatic and therefore are not available for comparison
with studies in the severely symptomatic patients.
Familial occurrence of hypertrophic cardiomyopathy.
Familial occurrence of hypertrophic cardiomyopathy was
identified in the pedigrees of 5 of the IO severely sympto-
matic patients and 11 of the 17 asymptomatic or only mildly
symptomatic patients. In the remaining 11 study patients,
no relative was known to have hypertrophic cardio-
myopathy, but systematic echocardiographic studies were
not performed in relatives of these patients.
Figure 5. Case 6 (Table 2). Serial M-mode echocardiograms
showing progressive thinning of the ventricular septum (VS). Left
ventricular internal dimension (LVIDct) remained substantiallyun-
changed. A, At age 38, ventricular septal thickness is 30 mm and
left ventricular internal dimension is 50 mm (this echocardiogram
is not the initial study obtained in this patient). B, Nine years
later, ventricular septal thickness is 22 mm and left internal ven-
tricular dimension is 50 mm.
ejection fraction ranged from 25 to 45% (mean 38)
(Table 2).
Left ventricular diastolic function could be assessed in 9
of the IO patients and was impaired in 8 (Table 2). Peak
filling rate was reduced « 2.5 end-diastolic volume/s) in
each of the eight patients (range 0.8 to 2.4 end-diastolic
volume/s), and time to peak filling rate was prolonged (> 180
ms, range 191 to 247) in four.
In addition, long-term follow-up radionuclide angio-
graphic studies were available in 3 of the IO patients (time
interval between the two studies was 3 to 4 years). Between
the initial and the most recent evaluation, left ventricular
ejection fraction decreased considerably in each of the three
patients (from 50 to 43%, 40 to 27% and 43 to 25%, re-
spectively) (Table 2).
Radionuclide angiographic studies were not performed
in the 17 patients who were asymptomatic or only mildly
Discussion
Ventricular function in hypertrophic cardiomyop-
athy. In most symptomatic patients with nonobstructive
hypertrophic cardiomyopathy, left ventricular performance
is characterized by severely impaired diastolic function with
prolonged isovolumic relaxation and reduced rate of left
ventricular filling; systolic function, however, is normal or
supernormal with increased ejection fraction and rate of
ejection (1-3,12,15-17). Marked left ventricular hypertro-
phy is believed to contribute importantly to the left ven-
tricular diastolic impairment in these patients (1-3). How-
ever, we have recently shown that severe diastolic
abnormalities may occur in patients with hypertrophic car-
diomyopathy who have only mild localized left ventricular
hypertrophy (4). This observation suggests that factors other
than marked hypertrophy may playa major role in the gen-
esis of left ventricular dysfunction in patients with hyper-
trophic cardiomyopathy and that the primary cardiornyo-
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pathic process in this disease may not be limited to the
thickened areas of the left ventricular wall. However, the
occurrence of severe cardiac symptoms in the presence of
only mild localized left ventricular hypertrophy has not been
previously fully appreciated in patients with hypertrophic
cardiomyopathy.
Severe symptoms in the presence of mild left ventric-
ular hypertrophy. In the present investigation , we iden-
tified 10 severely symptomatic patients with nonobstructive
hypertrophic cardiomyopathy who showed only mild lo-
calized left ventricular hypertrophy on echocardiographic
studies . Although left ventricular diastolic function was im-
paired in virtually all these patients, a critical and unex-
pected finding was that systolic function (usually supernor-
mal in patients with hypertrophic cardiomyopathy) was
depressed in 6 of the 10. Although left ventricular cavity
dimension showed a substantial increase during the follow-
up period in six patients, absolute cavity dimension re-
mained within normal limits in five of the six; four patients
also demonstrated thinning of the ventricular septum. Con-
versely , left ventricular internal dimension and wall thick-
ness remained unchanged in each of the 17 control patients
with nonobstructive hypertrophic cardiomyopathy and mild
localized hypertrophy, but no or only mild symptoms.
Relation to the dilated phase of hypertrophic cardio-
myopathy. Several previous reports (18-23) have de-
scribed , in a relatively small number of patients, the evo-
lution of "typical" hypertrophic cardiomyopathy (that is,
hypertrophied , hyperdynamic and nondilated) into a phase
morphologically and functionally resembling a dilated car-
diomyopathy, similar to that observed in one of our patients
(Case 5, Table 2). However, in each of our remaining study
patients with impaired systolic function and progressive in-
crease in left ventricular internal dimension, absolute cavity
dimension remained within normal limits, and the progres-
sive increase in left ventricular size would not have been
identified without serial echocardiographic measurements.
This evolution of hypertrophic cardiomyopathy into (1
phase characterized by depressed systolic function but nor-
mal (in absolute terms) left ventricular cavity dimension
may have important hemodynamic consequences. Indeed,
the decreased ejection fraction in a nondilated noncompliant
left ventricle may critically reduce stroke volume and in-
crease left ventricular filling pressures, leading to severe
symptoms of cardiac failure .
Study limitations. We emphasize that , because of the
selection criteria used in the present investigation , our study
group does not reflect the prevalence of asymptomatic or
severely symptomatic patients among those with hyper-
trophic cardiomyopathy who have only mild left ventricular
hypertrophy . For the same reasons, the present study cannot
define the incidence of systolic dysfunction, wall thinning
and relative cavity dilation in the overall population of pa-
tients with hypertrophic cardiomyopathy. Such questions
can be answered definitively only by a study performed in
a much larger and consecutively selected group of patients
with this disease.
In the present investigation . we used the peak rate and
time to peak rate of rapid diastolic filling as indexes of left
ventricular diastolic function . However, it should be em-
phasized that these indexes cannot be considered pure mea-
sures of diastolic performance. because they may also be
influenced by other variables such as left ventricular systolic
function and the loading conditions of the ventricle . There-
fore. it is possible that the abnormal indexes of diastolic
function identified in some of our patients could be ex-
plained, in part, by their decreased ejection fraction.
Pathophysiologic mechanisms. The pathophysiologic
mechanisms responsible for wall thinning, cavity enlarge-
ment and impaired ventricular function exhibited by our
patients with hypertrophic cardiomyopathy remain to be
determined. Such changes could be due to progression of
the underlying primary cardiomyopathic process . Alterna-
tively, myocardial ischemia may be an independent impor-
tant determinant of such morphologic and functional alter-
ations . This hypothesis is suggested by the decreased
vasodilator reserve (24.25) and reversible thallium-20l
myocardial perfusion abnormalities (26-28) found in pa-
tients with hypertrophic cardiomyopathy during clinical
studies, as well as the fibrosis or even transmural scarring
identified at necropsy (29,30) and often associated with
abnormal intramural coronary arteries (31).
Conclusion. This study identified a subgroup of patients
with nonobstructive hypertrophic cardiomyopathy who ex-
perienced severe cardiac symptoms in the presence of only
mild localized left ventricular hypertrophy. In the majority
of these patients, we identified a progressive increase in left
ventricular cavity dimension (but without absolute left ven-
tricular dilation) or ventricular septal thinning, or both, as-
sociated with both diastolic and systolic dysfunction. Evo-
lution of hypertrophic cardiomyopathy into a phase
characterized by impaired systolic function while the left
ventricle is still nondilated may represent an important as-
pect of the natural history of the disease.
We are grateful to Imogene Surrey for superb secretarial assistance in the
preparat ion of this manuscript and to Sandra York. for expert technical
assistance in the acquisition of data .
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